Download Full Text (582 KB)
Neonatal Abstinence Syndrome (NAS) is a complex disorder that manifests with neurologic, gastrointestinal, and musculoskeletal disturbances and is most often associated with opioid withdrawal. In the US, 6 out of 1,000 babies are born to mothers who used opioids during their pregnancy. These babies go on to develop NAS. Androscoggin County, where Central Maine Medical Center is located, has an even higher rate of babies with NAS: 100 out of 1,000. Most institutions use the Finnegan Neonatal Abstinence Scoring System (FNASS) to guide pharmacologic treatment. This system assigns a score based on 21 clinical signs of withdrawal with a score ≥8 indicating a need for pharmacologic treatment. This system has never been validated nor has its score cutoffs been tested which may lead to over or under treatment of babies experiencing NAS. Eat, Sleep, Console is a novel approach which has shown to decrease average length of stay, pharmacologic treatment, and healthcare costs.
Central Maine Medical Center
pediatrics, newborn care, neonatal abstinence syndrome, Maine, eat sleep console, opioid withdrawal
Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.
Medical Education | Primary Care
Patton, Kathryn, "Eat, Sleep, Console for Neonatal Abstinence Syndrome Babies" (2019). Family Medicine Clerkship Student Projects. 442.